Conference item icon

Conference item

Maternal circulating levels of syncytiotrophoblast vesicles expressing Dipeptidyl Peptidase IV (DPPIV) are increased in Gestational Diabetes Mellitus

Abstract:
Gestational Diabetes Mellitus (GDM) is the most common metabolic disorder of pregnancy. Plasma of women with GDM display lower levels of glucagon-like peptide-1 (GLP-1), which increases insulin secretion and thus regulates glucose homeostasis. GLP-1 concentration normalizes after delivery; suggesting placental involvement in regulating maternal glucose-dependent insulin secretion. The syncytiotrophoblast of the human placenta produces and secretes extracellular vesicles (STBEVs) into the maternal circulation, by which the placenta may affect maternal metabolism. We analysed the presence of dipeptidyl peptidase IV (DPPIV), a potent inhibitor of GLP-1, on STBEVs in GDM and normal pregnancy
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.placenta.2018.06.005

Authors

More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Women's & Reproductive Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Women's & Reproductive Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Social Sciences Division
Department:
Said Business School
Role:
Author


Publisher:
Elsevier
Host title:
Placenta
Journal:
2018 International Federation of Placenta Associations Meeting (IFPA 2018) More from this journal
Volume:
69
Pages:
E7
Publication date:
2018-09-10
DOI:
EISSN:
1532-3102
ISSN:
0143-4004


Pubs id:
pubs:921715
UUID:
uuid:84b99b07-03ae-41f8-a3fc-6545b0b487cc
Local pid:
pubs:921715
Source identifiers:
921715
Deposit date:
2018-10-02
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP